Clinical trial results detail how topical calcipotriol plus 5-fluorouracil (5-FU) leverages the adaptive immune system…
DISEASES
The FDA approval on September 29, 2023, for ‘class III de novo’ blood tests to…
Study confirms that the use of anti-tumor necrosis factor drugs dramatically reduces the likelihood of…
A study led by Rutgers professor finds more liberal blood transfusions have more favorable results…
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in…
The findings showed that CBD did not significantly change scan-related anxiety when compared to a…
The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence…
Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free survival in patients with…
Low levels of bacteria like E. coli and Lactobacillus in our urine come from communities…
“These initial results suggest that individuals with SCD have a significantly higher cellular senescence burden…
